Path of Silibinin from diet to medicine: A dietary polyphenolic flavonoid having potential anti-cancer therapeutic significance
In the last few decades, targeting cancer by the use of dietary phytochemicals has gained
enormous attention. The plausible reason and believe or mind set behind this fact is …
enormous attention. The plausible reason and believe or mind set behind this fact is …
[HTML][HTML] Silymarin and cancer: A dual strategy in both in chemoprevention and chemosensitivity
Silymarin extracted from milk thistle consisting of flavonolignan silybin has shown
chemopreventive and chemosensitizing activity against various cancers. The present review …
chemopreventive and chemosensitizing activity against various cancers. The present review …
The anticancer properties of silibinin: its molecular mechanism and therapeutic effect in breast cancer
A Binienda, S Ziolkowska… - Anti-Cancer Agents in …, 2020 - ingentaconnect.com
Background: Silibinin (SB), the main component of Silymarin (SM), is a natural substance
obtained from the seeds of the milk thistle. SM contains up to 70% of SB as two isoforms: A …
obtained from the seeds of the milk thistle. SM contains up to 70% of SB as two isoforms: A …
[HTML][HTML] TRAIL-sensitizing effects of flavonoids in cancer
A Luiz-Ferreira, T Pacifico, ÁC Cruz, F Laudisi… - International Journal of …, 2023 - mdpi.com
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) represents a promising
anticancer agent, as it selectively induces apoptosis in transformed cells without altering the …
anticancer agent, as it selectively induces apoptosis in transformed cells without altering the …
Ursolic acid promotes the sensitization of rhTRAIL-resistant triple-negative breast cancer
JM Manouchehri, M Kalafatis - Anticancer research, 2018 - ar.iiarjournals.org
Background/Aim: Triple-negative breast cancer (TNBC) can be characterized as the
deadliest breast cancer type considering the lack of efficacious therapeutics. Recombinant …
deadliest breast cancer type considering the lack of efficacious therapeutics. Recombinant …
Effects of sepantronium bromide (YM-155) on the whole transcriptome of MDA-MB-231 cells: Highlight on impaired ATR/ATM fanconi anemia DNA damage response
EA Mazzio, CA Lewis, R Elhag… - Cancer Genomics & …, 2018 - cgp.iiarjournals.org
Sepantronium bromide (YM-155) is believed to elicit apoptosis and mitotic arrest in tumor
cells by reducing (BIRC5, survivin) mRNA. In this study, we monitored changes in survivin …
cells by reducing (BIRC5, survivin) mRNA. In this study, we monitored changes in survivin …
Ablehnung einer konventionellen Therapie durch Patientinnen mit Mammakarzinom, die komplementäre und alternative Behandlungen anwendeten. Welche Gründe …
A Schleicherdt - 2021 - jlupub.ub.uni-giessen.de
Der aktuelle Forschungstand von Mammakarzinompatientinnen die alternative und
komplementäre Therapien anwenden und konventionelle Therapien ablehnten, ist …
komplementäre Therapien anwenden und konventionelle Therapien ablehnten, ist …
RhTRAIL with Sensitizing Agents for Breast Carcinoma Treatment
JM Manouchehri - 2018 - rave.ohiolink.edu
Recombinant human tumor necrosis factor-related apoptosis-inducing ligand (rhTRAIL)
shows therapeutic potential for cancer with its ability to induce apoptosis in cancer cells …
shows therapeutic potential for cancer with its ability to induce apoptosis in cancer cells …
[CITATION][C] The Future of Breast Cancer Treatment Relies on Getting in Touch with Mother Nature and Stepping Back on the TRAIL
JM Manouchehri, M Kalafatis - Clin Oncol, 2018